Fresenius Medical Care AG ADR FMS
News
Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024
Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.
U.S. stocks score fourth day of gains after Fed minutes, wholesale inflation data
Dialysis-company stocks slide after Ozempic trial's success in treating kidney disease
Fresenius Shares Slump After Novo Nordisk Kidney Disease Trial Shows Efficacy